This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_PROSTATE_EXALLC for full statistics.
Malignant neoplasm of prostate
C3_PROSTATE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
19678 |
4. Check minimum number of eventsNone |
19678 |
5. Include endpointsNone |
19678 |
6. Filter based on genotype QC (FinnGen only) |
19678 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of prostate
based on the number of shared cases.
Similar with more cases:
- malignant neoplasm of male genital organs
- Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 19678 | - | 19678 |
| Unadjusted period prevalence (%) | 8.67 | - | 8.67 |
| Median age at first event (years) | 69.23 | - | 69.23 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 11346
- Matched controls
- 79804
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
NK6AN
NOMESCO Finland
Total body bone isotope imaging
72.4
323.0
1369
151
Y77
ICPC
Malignant neoplasm prostate
282.3
323.0
2140
66
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
323.0
438
*
L02BB04
ATC
enzalutamide; oral
+∞
323.0
500
*
116
Kela drug reimbursment
Prostate cancer
+∞
323.0
5838
*
L02AE02
ATC
leuprorelin; implant, parenteral
9274.0
323.0
3646
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
3876.2
323.0
11000
650
N40
ICD-10 Finland
Hyperplasia of prostate
2.2
323.0
5160
21741
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
17.1
323.0
3387
1936
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
64.9
323.0
677
78
J01EA01
ATC
trimethoprim; systemic
3.8
323.0
2531
5647
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
937.3
323.0
863
7
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
9.0
323.0
1037
883
D40.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Prostate
14.2
323.0
767
406
WF002
NOMESCO Finland
Radical radiotherapy
19.7
323.0
2391
1066
KE1BG
NOMESCO Finland
MRI of prostate
26.5
323.0
509
141
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
37.5
323.0
4737
1494
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
81.7
323.0
1271
123
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
14.9
323.0
1351
719
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
29.5
323.0
680
172
UKC02
NOMESCO Finland
Cystoscopy
2.6
323.0
3113
9982
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.0
323.0
3277
9543
L02BX02
ATC
degarelix; parenteral
+∞
323.0
821
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
6.1
323.0
4642
8150
KC1GB
NOMESCO Finland
Cystography with X-ray
55.8
323.0
693
93
XJH00
NOMESCO Finland
Transanal ultrasonography
5.7
323.0
2267
3352
L02AE03
ATC
goserelin; implant
1115.7
323.0
593
*
KFC10
NOMESCO Finland
Bilateral orchiectomy
260.0
323.0
395
11
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
4503599627370496.0
323.0
11136
27
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
196.8
323.0
1043
41
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
323.0
633
*
KE1DG
NOMESCO Finland
Very extensive MRI of prostate
19.3
323.0
597
229
KEB00
NOMESCO Finland
Biopsy of prostate
16.5
323.0
650
293
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.8
323.0
4046
13083
G04BE03
ATC
sildenafil; oral
37.3
323.0
823
167
XKD00
NOMESCO Finland
Uroflowmetry
7.3
323.0
6088
10941
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
352.5
323.0
2673
69
XX3DW
NOMESCO Finland
Time consuming IT work
6.2
323.0
2247
3046
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
14.0
323.0
629
334
TKE00
NOMESCO Finland
Needle biopsy of prostate
14.0
323.0
2283
1413
G03HA01
ATC
cyproterone; systemic
135.7
323.0
463
25
L02AE04
ATC
triptorelin; parenteral
+∞
323.0
491
*
L02BB03
ATC
bicalutamide; oral
2550.2
323.0
2383
8
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
4.4
323.0
2805
5532
ZXC96
NOMESCO Finland
Robot assisted procedure
55.4
323.0
1815
273
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
32.7
323.0
1020
240
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
187.2
323.0
1340
57
G04CA02
ATC
tamsulosin; oral
2.2
313.0
5372
23285
L02BX03
ATC
abiraterone; oral
+∞
305.0
335
*
J01MA02
ATC
ciprofloxacin; systemic
2.2
302.7
5137
22039
G04BE01
ATC
alprostadil; parenteral, urethral
7.7
302.2
797
776
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
9.9
293.1
664
496
M05BX04
ATC
denosumab; parenteral
9.5
289.2
671
524
KDE20
NOMESCO Finland
Removal of foreign body from urethra
21.8
277.7
457
153
JN4BD
NOMESCO Finland
Extensive body CT
3.1
273.0
1793
4523
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
15.9
259.7
475
218
ZX070
NOMESCO Finland
Intensity modified radiotherapy
10.4
258.1
571
406
1850A
ICD-9 Finland
Malignant neoplasm of prostate[NEOPLASMA MALIGNUM PROSTATAE]
217.0
254.3
299
10
WF090
NOMESCO Finland
Profylactic radiotherapy
178.0
248.9
296
12
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
10.8
245.6
532
362
KE1CG
NOMESCO Finland
Extensive MRI of prostate
29.9
242.8
367
89
TKE10
NOMESCO Finland
Puncture of prostate
86.9
238.0
301
25
WF003
NOMESCO Finland
Adjuvant radiotherapy
7.9
234.0
602
559
ZX090
NOMESCO Finland
Other technic of radiotherapy
9.1
230.7
547
442
K62.7
ICD-10 Finland
Radiation proctitis
260.6
219.0
255
7
N39.3
ICD-10 Finland
Stress incontinence
22.6
213.4
347
111
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
40.1
211.5
300
54
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
27.6
205.7
317
83
L01XX11
ATC
estramustine; systemic
+∞
200.8
221
*
3054
Kela drug reimbursment
NA
+∞
196.2
216
*
1523
Kela drug reimbursment
NA
+∞
196.2
216
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
114.9
195.1
240
15
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
71.9
193.3
250
25
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
11.9
182.2
375
228
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
35.0
177.1
258
53
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.0
173.2
631
929
JN4AD
NOMESCO Finland
Body CT examination
2.9
170.7
1210
3145
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
168.6
3011
12398
L02BB01
ATC
flutamide; oral
1286.9
167.6
187
*
B01AB05
ATC
enoxaparin; parenteral
1.9
159.7
3249
13982
OAB42
NOMESCO Finland
Guidance related to known health problem
50.9
156.8
213
30
N02BE01
ATC
paracetamol; systemic, rectal
1.8
154.6
8686
51246
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.2
152.9
656
1142
KED22
NOMESCO Finland
Transurethral resection of prostate
2.5
145.9
1364
4158
N42.9
ICD-10 Finland
Disorder of prostate, unspecified
5.7
143.8
465
593
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.7
143.2
4314
20926
G04BE30
ATC
drugs used in erectile dysfunction - combinations
201.8
143.2
169
6
R31
ICD-10 Finland
Unspecified haematuria
2.2
142.7
1755
6126
Y06
ICPC
Prostate symptom/complaint
3.6
137.6
705
1435
R33
ICD-10 Finland
Retention of urine
2.3
136.7
1534
5122
G04BD12
ATC
mirabegron; oral
2.6
133.7
1117
3187
ZX080
NOMESCO Finland
Image guided radiotherapy
9.6
132.7
303
227
ZX112
NOMESCO Finland
Subcutaneous
6.7
131.3
375
405
WZC30
NOMESCO Finland
Teaching
2.2
129.9
1563
5383
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
46.7
128.6
177
27
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
95.1
127.9
160
12
7512
FHL
Orchidectomy (bilateral)
1030.7
127.6
143
*
JN4LR
NOMESCO Finland
Extensive PET-CT of receptors in whole body
247.7
120.0
140
*
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
57.8
109.8
146
18
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
+∞
107.9
119
*
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
432.6
106.9
122
*
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
18.1
103.7
180
71
TQW40
NOMESCO Finland
Remowal of suture of skin
2.7
102.9
824
2280
H02AB02
ATC
dexamethasone; systemic
2.3
101.7
1063
3396
U04
ICPC
Incontinence urine
3.8
101.1
476
898
Z12.5
ICD-10 Finland
Special screening examination for neoplasm of prostate
8.0
100.3
253
226
N02AX02
ATC
tramadol; systemic, rectal
1.5
96.3
4667
24845
G04CA01
ATC
alfuzosin; oral
1.7
95.1
2381
10640
G04BD08
ATC
solifenacin; oral
2.7
93.8
723
1953
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.5
93.4
487
1001
TKC52
NOMESCO Finland
Patient education concerning pelvic floor contraction exercises
64.5
90.3
118
13
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
13.1
89.8
176
96
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
20.0
88.9
149
53
TKC20
NOMESCO Finland
Catheterisation of bladder
2.1
83.6
1036
3568
WB221
NOMESCO Finland
Demanding neoadjuvant hormone therapy of malignancy
223.0
81.1
95
*
8000/3-C61.9
ICD-O-3
Neoplasm, malignant of prostate gland
+∞
80.7
89
*
ZXC20
NOMESCO Finland
Use of chemical agents
4.7
77.5
296
456
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
37.2
76.9
110
21
Z51.0
ICD-10 Finland
Radiotherapy session
6.9
76.9
214
223
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
29.4
74.4
112
27
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
9.8
74.0
166
121
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
73.9
1699
7327
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
36.9
72.6
104
20
2BX02
NOMESCO Finland
NA
+∞
72.5
80
*
KE1DR
NOMESCO Finland
Prostate metabolic PET with CT
148.7
70.0
84
*
G04BE09
ATC
vardenafil; oral
50.7
68.8
93
13
KDW96
NOMESCO Finland
Other operations on urethra
33.8
68.6
100
21
HB000
NOMESCO Finland
Profylactic radiotherapy of mammary gland
+∞
67.0
74
*
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
5.0
66.9
239
343
L03AA13
ATC
pegfilgrastim; parenteral
3.8
66.2
310
582
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
5.7
65.7
210
264
KD1GB
NOMESCO Finland
Uretrocystogpaphy with X-ray
17.6
65.4
114
46
R74.9
ICD-10 Finland
Abnormal level of unspecified serum enzyme
9.0
64.2
150
118
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
22.8
64.2
103
32
KDG43
NOMESCO Finland
Transobturatorial sling urethrocystopexy
179.5
64.1
76
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.5
63.8
542
1543
ZX050
NOMESCO Finland
Stereotactic radiotherapy
8.0
62.4
156
138
WX402
NOMESCO Finland
General anaesthesia
1.7
61.6
1451
6275
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
3.9
59.2
272
502
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.6
57.2
467
1299
WF004
NOMESCO Finland
Palliative radiotherapy
3.5
57.0
293
595
XX7FT
NOMESCO Finland
Radioyttrium therapy with connected antibody
231.9
56.5
66
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
3.4
56.2
298
621
ZX022
NOMESCO Finland
LDR radiotherapy within tissue
157.9
56.1
67
*
XKG00
NOMESCO Finland
Artificial induction of erection
20.4
55.5
92
32
N02AA05
ATC
oxycodone; systemic
1.6
55.5
1603
7325
N30.4
ICD-10 Finland
Irradiation cystitis
153.2
54.3
65
*
U77
ICPC
Malignant neopl urinary tract other
43.6
53.5
74
12
L02AE01
ATC
buserelin; implant, nasal, parenteral
+∞
53.4
59
*
L03AA14
ATC
lipegfilgrastim; parenteral
5.4
53.0
175
230
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
3.5
52.7
272
555
TKC22
NOMESCO Finland
Catheterisation instruction
3.0
52.3
337
809
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
21.5
52.2
85
28
JN4CD
NOMESCO Finland
Very extensive body CT
2.4
51.3
489
1478
R86.1
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of hormones
9.4
50.5
115
87
XKD03
NOMESCO Finland
Urethral pressure profilometry
4.7
49.0
185
283
R86.9
ICD-10 Finland
Abnormal findings in specimens from male genital organs, unspecified abnormal finding
8.4
49.0
119
101
J01MA12
ATC
levofloxacin; systemic
1.5
47.9
2069
10373
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
4.7
47.4
178
271
G04BE08
ATC
tadalafil; oral
23.9
45.0
71
21
Z51.5
ICD-10 Finland
Palliative care
2.0
44.4
672
2491
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
19.4
44.1
74
27
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
31.8
42.9
63
14
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
31.3
42.1
62
14
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
4.6
42.1
159
244
J01MA01
ATC
ofloxacin; systemic
1.7
40.6
1004
4372
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.1
40.5
525
1828
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
6.1
40.5
121
141
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
7.2
40.0
106
104
KDK10
NOMESCO Finland
Implantation of artificial urinary sphincter around bulbar urethra
47.7
39.8
54
8
A79
ICPC
Malignancy NOS
4.3
39.8
160
262
XX1AD
NOMESCO Finland
Other CT-examination
8.1
39.7
98
86
1CD02
NOMESCO Finland
NA
19.4
39.5
66
24
WF099
NOMESCO Finland
Other radiotherapy
8.3
39.2
95
81
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
11.1
38.5
80
51
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
38.4
982
4313
D07.5
ICD-10 Finland
Carcinoma in situ: Prostate
50.5
37.2
50
7
KE003
NOMESCO Finland
Adjuvant radiotherapy of prostata and seminal vesicles
+∞
36.2
40
*
XX7AT
NOMESCO Finland
Radiation therapy with Radium-223
+∞
36.2
40
*
KCC10
NOMESCO Finland
Cystoprostatectomy
5.0
35.6
124
175
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
8.8
35.4
83
67
L02AA02
ATC
polyestradiol phosphate; parenteral
+∞
35.3
39
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
8.0
35.2
87
77
NK6SN
NOMESCO Finland
Bone SPECT
32.7
35.1
51
11
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.5
34.1
1182
5602
N30.0
ICD-10 Finland
Acute cystitis
1.8
34.0
620
2454
OAB77
NOMESCO Finland
Discussion on exercise habits and instruction concerning use of sports and fitness services
+∞
32.6
36
*
G04BD07
ATC
tolterodine; oral
2.1
32.4
409
1410
KE1DM
NOMESCO Finland
Very extensive MRI of prostate (more than 1.5 T)
39.7
32.2
45
8
A04AA02
ATC
granisetron; systemic, transdermal
1.9
31.8
484
1795
8010/3-C61.9
ICD-O-3
Carcinoma, NOS, of prostate gland
+∞
31.7
35
*
N99.1
ICD-10 Finland
Postprocedural urethral stricture
4.8
31.6
115
171
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
8.7
31.6
74
60
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.2
31.6
348
1129
7455
FHL
Retropubic total prostatectomy
42.3
30.5
42
7
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
6.0
29.4
88
104
J01CA08
ATC
pivmecillinam; oral
1.7
29.1
642
2699
R39.1
ICD-10 Finland
Other difficulties with micturition
2.0
29.0
382
1341
WX110
NOMESCO Finland
Local anesthesy
1.3
28.9
5508
34217
Y78
ICPC
Malign neopl male genital other
36.1
28.9
41
8
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
28.8
2693
15264
WX320
NOMESCO Finland
Spinalanesthesy
1.4
28.4
1894
10188
7461
FHL
Needle biopsy in the operating room
4.3
28.4
113
185
5BX04
NOMESCO Finland
NA
32.1
28.2
41
9
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.2
28.0
302
972
WVA20
NOMESCO Finland
Medicine administration
2.6
27.6
221
610
B01AB10
ATC
tinzaparin; parenteral
1.7
27.0
559
2303
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
2.8
26.8
185
468
N35.9
ICD-10 Finland
Urethral stricture, unspecified
2.7
26.8
196
514
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.9
26.4
444
1710
XX1XQ
NOMESCO Finland
Other SPECT-CT
112.8
26.3
32
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
2.0
26.3
369
1330
WVA30
SPAT
NA
2.4
26.1
247
747
KDV10
NOMESCO Finland
Internal urethrotomy
2.6
25.0
198
544
A28
ICPC
Limited function/disability NOS
1.4
24.8
1263
6463
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.6
24.8
645
2841
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
8.5
24.6
58
48
A07EA02
ATC
hydrocortisone; rectal
2.5
24.3
206
588
WB201
NOMESCO Finland
Simple neoadjuvant hormone therapy of malignancy
198.1
23.9
28
*
XKC03
NOMESCO Finland
Water cystometry
2.5
23.7
206
597
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
11.1
22.9
47
30
C05AA08
ATC
fluocortolone; rectal, topical
1.4
22.8
1151
5878
KEC10
NOMESCO Finland
Perineal radical prostatectomy
+∞
22.6
25
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
5.9
22.5
68
82
J01MA06
ATC
norfloxacin; oral
1.5
22.5
812
3871
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.6
22.4
700
3229
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
22.3
2189
12423
KE1AE
NOMESCO Finland
Percutaneous utlrasound examination fo prostata
4.9
22.2
78
113
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.2
22.1
4164
25551
OAB75
NOMESCO Finland
Nutritional guidance related to maintaining health
36.4
22.0
31
6
B02AA02
ATC
tranexamic acid; systemic
1.7
21.9
535
2314
UJF32
NOMESCO Finland
Coloscopy
1.3
21.9
2183
12410
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
2.0
21.7
304
1094
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.9
21.6
139
338
D40.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Male genital organ, unspecified
8.0
21.4
52
46
U06
ICPC
Haematuria
2.2
21.3
241
796
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
21.3
6039
38594
KA3EB
NOMESCO Finland
Antegrade pyelography
4.4
21.2
82
132
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
7.5
20.9
53
50
SPAT1254
SPAT
Administration of medicine
1.4
20.6
1146
5950
G04CB02
ATC
dutasteride; oral
1.4
20.6
972
4897
ZXA10
NOMESCO Finland
Bilateral
1.4
20.6
1354
7233
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.3
20.2
1769
9864
SPAT1167
SPAT
Insertion of urinary catheter
1.8
20.2
357
1401
K62.8
ICD-10 Finland
Other specified diseases of anus and rectum
4.3
20.1
79
129
JGA28
NOMESCO Finland
Endoscopic contact coagulation in rectum
26.4
19.9
30
8
KE099
NOMESCO Finland
Other radiotherapy of prostata and seminal vesicles
+∞
19.9
22
*
J01DB01
ATC
cefalexin; oral
1.2
19.8
7427
48615
C61, D400
ICD-10 Finland
NA
162.0
19.5
23
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
2.1
19.5
243
836
R4110
NOMESCO Finland
Physiotherapy
1.3
19.5
2181
12563
G04BD11
ATC
fesoterodine; oral
2.2
19.4
213
694
D64.9
ICD-10 Finland
Anaemia, unspecified
1.4
19.4
1004
5146
KDV20
NOMESCO Finland
Submucous urethral injection
23.5
19.3
30
9
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.4
18.5
1090
5709
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.4
18.4
866
4360
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
19.2
18.3
30
11
U76
ICPC
Malignant neoplasm of bladder
6.5
18.1
50
54
SPAT1053
SPAT
Memory test
1.4
18.1
1160
6163
A55
ICPC
General and Unspecified, Local injection/infiltration
3.3
18.1
95
201
WB211
NOMESCO Finland
Neoadjuvant hormone therapy of malignancy
+∞
18.1
20
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.6
18.0
216
2684
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
3.5
17.7
87
175
-50
ICPC
Medication/prescr/renewal
1.8
17.7
326
1299
U08
ICPC
Urinary retention
2.0
17.6
222
769
SPAT1262
SPAT
Handing over of treatment supplies
1.3
17.4
1760
9988
U29
ICPC
Urinary symptom/complaint other
2.2
17.4
195
643
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
2.0
17.3
239
860
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
1.3
17.2
1468
8141
Z02.4
ICD-10 Finland
Examination for driving licence
1.2
17.1
2474
14659
U05
ICPC
Urination problems other
1.7
17.0
369
1545
JN2BM
NOMESCO Finland
Lower part of abdomen MRI examination with Tesla magnet
51.7
16.7
22
*
SPAT1325
SPAT
Vaccination
1.2
16.5
2549
15205
Y50
ICPC
Male Genital, Medication/prescr/renewal
7.8
16.4
40
36
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
16.4
902
4668
SPAT1263
SPAT
Sampling
1.2
16.3
3198
19537
KE2KT
NOMESCO Finland
Marker implantation in prostate under radiological guidance
+∞
16.3
18
*
A98
ICPC
Health maint/preventive medicine
1.2
16.2
8696
58213
SPAT1304
SPAT
Counselling and guidance related to ageing
1.6
15.8
474
2164
6000A
ICD-9 Finland
Hyperplasia of prostate[HYPERPLASIA PROSTATAE]
1.7
15.8
337
1406
U13
ICPC
Bladder symptom/complaint other
2.2
15.7
161
511
UKD02
NOMESCO Finland
Urethroscopy
3.7
15.7
71
134
103
Kela drug reimbursment
Diabetes, insulin-treated
0.8
15.6
2236
18432
TQX05
NOMESCO Finland
Skin puncture, unspecified location
7.4
15.6
39
37
KE2JT
NOMESCO Finland
Demanding radiation source placement in prostate under ultrasound guidance
+∞
15.4
17
*
KEW98
NOMESCO Finland
Other transluminal endoscopic operation on prostate
+∞
15.4
17
*
H91.1
ICD-10 Finland
Presbycusis
1.5
15.2
488
2263
7451
FHL
Transurethral adenoma removal
1.8
15.1
249
957
KE2AT
NOMESCO Finland
Cytologoy of prostata with ultrasound guidance
14.6
15.1
27
13
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.3
15.1
1610
9187
KDK40
NOMESCO Finland
Removal of artificial urethral sphincter
126.7
15.1
18
*
A06AD11
ATC
lactulose; oral
1.3
14.9
1431
8054
JGA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in rectum
23.1
14.9
23
7
D29.1
ICD-10 Finland
Benign neoplasm: Prostate
3.4
14.9
75
155
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
14.9
8094
53941
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
2.2
14.8
152
483
S18
ICPC
Laceration/cut
1.2
14.8
3530
21930
N30.9
ICD-10 Finland
Cystitis, unspecified
1.8
14.6
267
1062
R86
ICD-10 Finland
Abnormal findings in specimens from male genital organs
8.3
14.5
34
29
L01AA04
ATC
NA
+∞
14.5
16
*
1CD04
NOMESCO Finland
NA
+∞
14.5
16
*
ZX100
NOMESCO Finland
Oral
2.3
14.3
134
408
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.2
14.2
1806
10515
SPAT1312
SPAT
General health counselling
1.2
14.2
2173
12914
JFA45
NOMESCO Finland
Endoscopic contact coagulation in colon
3.6
14.2
67
132
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.8
14.1
237
917
1530
FHL
Urethrocystoscopy
1.8
13.9
239
933
TPH07
NOMESCO Finland
Cathetrisation of artery
1.3
13.9
917
4890
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
2.6
13.9
108
299
U28
ICPC
Limited function/disability (U)
2.6
13.8
107
296
N48.4
ICD-10 Finland
Impotence of organic origin
1.7
13.7
276
1132
SPAT1088
SPAT
Blood transfusion
3.7
13.7
62
118
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
13.5
1591
9181
JN5AN
NOMESCO Finland
Total body isotope imaging
33.4
13.5
19
*
R60.0
ICD-10 Finland
Localized oedema
1.4
13.3
775
4048
WW500
NOMESCO Finland
Blood transfusion
1.6
13.3
328
1428
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.4
13.2
791
4154
TPH04
NOMESCO Finland
Cathetrisation of vein
1.2
13.1
1790
10500
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
13.0
1279
7217
N21.0
ICD-10 Finland
Calculus in bladder
2.2
13.0
134
428
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
0.2
13.0
18
525
U99
ICPC
Urinary disease other
3.2
12.9
72
160
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
1.8
12.9
230
910
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
4.5
12.9
47
73
F20.9
ICD-10 Finland
Schizophrenia, unspecified
0.3
12.9
24
601
WX290
NOMESCO Finland
Other blockade of nerve
1.2
12.8
2805
17243
M05BA02
ATC
clodronic acid; systemic
3.8
12.7
55
101
L57.0
ICD-10 Finland
Actinic keratosis
1.4
12.6
707
3675
D63.0
ICD-10 Finland
Anaemia in neoplastic disease
13.5
12.6
23
12
U07
ICPC
Urine symptom/complaint other
1.6
12.5
341
1523
JN3AD
NOMESCO Finland
Abdominal CT examination
1.4
12.5
626
3187
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
12.4
1331
7589
Z51.88
ICD-10 Finland
Other specified medical care
2.1
12.3
144
488
SPAT1301
SPAT
No procedures
1.2
12.2
2376
14439
H84
ICPC
Presbyacusis
1.8
12.0
225
905
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
6.3
11.9
33
37
-55
ICPC
Local injection/infiltration
3.1
11.9
68
156
A02BC02
ATC
pantoprazole; systemic
1.2
11.8
5633
36767
C08CA01
ATC
amlodipine; oral
1.2
11.8
3438
21622
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
2.1
11.8
138
468
N05AC02
ATC
thioridazine; oral
0.3
11.8
30
642
JR1AS
NOMESCO Finland
Restricted PET-MRI of receptors/transporters in body
+∞
11.8
13
*
Y77
ICD-10 Finland
Ophthalmic devices associated with adverse incidents
+∞
11.8
13
*
A06AH03
ATC
naloxegol; oral
2.3
11.6
105
317
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.2
11.6
1702
10054
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.3
11.5
1245
7101
KBJ60
NOMESCO Finland
Anastomosis of ureter to urethra with interposition of ileum
6.1
11.4
32
37
G04BD09
ATC
trospium; oral
2.1
11.3
130
439
U50
ICPC
Urological, Medication/prescr/renewal
23.9
11.2
17
5
WX872
NOMESCO Finland
Intensive care
0.6
11.2
255
2729
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
0.4
11.2
48
824
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.5
11.0
436
2122
A07DA03
ATC
loperamide; oral
1.6
11.0
308
1388
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
0.6
11.0
191
2165
-44
ICPC
Preventive immunization/medic
1.4
11.0
521
2629
2AE02
NOMESCO Finland
NA
+∞
10.9
12
*
8041/3-C61.9
ICD-O-3
Small cell carcinoma, NOS, of prostate gland
+∞
10.9
12
*
SPAT1153
SPAT
Removal of sutures
1.2
10.8
2603
16096
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
3.3
10.7
56
121
A04AA01
ATC
ondansetron; systemic, rectal
1.5
10.7
402
1938
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
1.4
10.6
494
2483
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
4.4
10.6
39
62
201
Kela drug reimbursment
Chronic cardiac insufficiency
0.7
10.5
375
3698
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
0.7
10.5
396
3869
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.8
10.5
1812
14760
WX704
NOMESCO Finland
Intubation
1.4
10.4
485
2439
KA1AE
NOMESCO Finland
Kidney ultrasound examination
1.7
10.3
220
923
130
Kela drug reimbursment
Malignant tumour
0.7
10.3
565
5218
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
2.0
10.2
139
503
N05AA02
ATC
levomepromazine; systemic
0.6
10.2
164
1893
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.3
10.2
679
3628
TKD00
NOMESCO Finland
Dilatation of urethra
2.7
10.2
72
191
N42.8
ICD-10 Finland
Other specified disorders of prostate
3.3
10.2
52
111
XKD11
NOMESCO Finland
NA
6.6
10.2
27
29
NF3AA
NOMESCO Finland
Femur X-ray examination
1.9
10.1
144
529
TKE05
NOMESCO Finland
Aspiration cytology of prostate
14.1
10.1
18
9
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
1.7
10.1
190
769
KCW98
NOMESCO Finland
Other transluminal endoscopic operation on bladder
5.8
10.0
29
35
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.8
10.0
1873
15164
N02AA01
ATC
morphine; systemic, rectal
1.9
10.0
143
527
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
10.0
1946
11802
N30
ICD-10 Finland
Cystitis
1.8
10.0
182
728
WC225
NOMESCO Finland
Demanding therapy of local tumor recidive with hormone
+∞
10.0
11
*
ZX137
NOMESCO Finland
To penis
+∞
10.0
11
*
U02
ICPC
Urinary frequency/urgency
1.4
9.9
460
2311
M05BA08
ATC
zoledronic acid; parenteral
18.8
9.9
16
6
WW200
SPAT
NA
0.7
9.8
357
3504
KH1AT
NOMESCO Finland
Urinary tract cathetrisation with ultrasound guidance
3.8
9.8
42
78
N04AA02
ATC
biperiden; systemic
0.4
9.6
39
685
N41.0
ICD-10 Finland
Acute prostatitis
1.6
9.6
258
1153
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.5
9.6
55
849
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
1.5
9.6
343
1638
R53
ICD-10 Finland
Malaise and fatigue
1.2
9.6
1356
7973
SPAT1168
SPAT
Catheterisation training
2.7
9.5
67
177
D64.8
ICD-10 Finland
Other specified anaemias
2.0
9.5
127
457
N06AX11
ATC
mirtazapine; oral
1.2
9.5
2150
13203
KED76
NOMESCO Finland
TUVP
2.2
9.4
97
312
KCV22
NOMESCO Finland
Transluminal endoscopic evacuation of blood clots from bladder
4.3
9.4
35
57
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.6
9.4
266
1204
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.4
9.3
477
2441
G04AC01
ATC
NA
2.1
9.3
101
333
P72
ICPC
Schizophrenia
0.3
9.2
21
470
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
5.3
9.1
28
37
XX7LT
NOMESCO Finland
Lutetium-177-PSMA treatment
+∞
9.0
10
*
KA1FN
NOMESCO Finland
Isotope renography
2.7
9.0
61
158
KWA00
NOMESCO Finland
Repair of wound dehiscence in urological surgery
7.4
9.0
22
21
C60.0
ICD-10 Finland
Malignant neoplasm: Prepuce
7.4
9.0
22
21
KGH10
NOMESCO Finland
Operation for phimosis
1.5
9.0
291
1359
ZX110
NOMESCO Finland
Intracutaneous
4.4
9.0
33
53
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
1.6
9.0
233
1034
JFA55
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in colon
3.2
9.0
47
103
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.4
8.9
482
2491
18599
ICD-8 Finland
Malignant neoplasm of prostate
77.4
8.9
11
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
8.9
2891
18254
H81
ICPC
Excessive ear wax
1.2
8.9
1318
7783
H25.8
ICD-10 Finland
Other senile cataract
1.3
8.9
804
4486
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.4
8.8
408
2052
N35.8
ICD-10 Finland
Other urethral stricture
3.0
8.8
51
120
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
5.9
8.8
25
30
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
0.7
8.7
363
3491
A10AA02
ATC
NA
0.6
8.7
115
1388
L04AA06
ATC
mycophenolic acid; systemic
0.4
8.6
34
601
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.3
8.6
935
5338
A10BK03
ATC
empagliflozin; oral
0.7
8.6
386
3666
SPAT1154
SPAT
Insertion or removal of subcutaneous medicine capsule
5.1
8.6
27
37
S50
ICPC
Skin, Medication/prescr/renewal
2.7
8.5
59
156
A10BA02
ATC
metformin; oral
0.9
8.5
2363
18586
N05CF01
ATC
zopiclone; oral
1.2
8.5
2697
16991
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.2
8.4
1051
6091
B01AE07
ATC
dabigatran etexilate; oral
1.5
8.4
315
1524
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
2.0
8.4
101
350
A10AA01
ATC
NA
0.5
8.3
53
789
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.2
8.3
2382
14889
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.3
8.3
75
230
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
0.5
8.2
75
997
N05AH02
ATC
clozapine; systemic
0.3
8.2
18
410
KE029
NOMESCO Finland
Radiotherapy of local recidive of tumor of prostata and seminal vesicles
+∞
8.1
9
*
KE1AK
NOMESCO Finland
Spectroscopy of prostate
+∞
8.1
9
*
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
0.4
8.1
34
588
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
0.6
8.0
107
1285
N05AF05
ATC
zuclopenthixol; systemic
0.3
8.0
12
334
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
0.2
7.9
9
293
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
1.3
7.9
540
2900
TQX20
NOMESCO Finland
Implantation of subcutaneous medicament implant
4.6
7.9
27
41
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
1.5
7.9
290
1397
U01
ICPC
Dysuria/painful urination
1.7
7.8
176
754
R50.9
ICD-10 Finland
Fever, unspecified
1.2
7.8
1079
6324
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
7.7
197
872
KDE12
NOMESCO Finland
Urethroscopic extraction of calculus of urethra
15.2
7.6
13
6
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.2
7.6
1988
12330
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
0.5
7.6
78
1005
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.4
7.6
437
2284
JN2BD
NOMESCO Finland
Extensive CT exmaniation of lower part of abdomen
3.8
7.5
32
60
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.1
7.5
2604
16488
T89
ICPC
Diabetes insulin dependent
0.6
7.5
96
1164
-1
SPAT
NA
1.6
7.5
180
785
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
1.4
7.5
309
1524
R32
ICD-10 Finland
Unspecified urinary incontinence
1.9
7.5
109
409
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.2
7.4
943
5480
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
1.9
7.4
108
405
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
1.5
7.4
230
1070
NF1AA
NOMESCO Finland
Hip X-ray examination
1.3
7.4
586
3218
KC1AT
NOMESCO Finland
Puncture of urinary bladder with ultrasound guidance
3.8
7.3
31
58
N03AG01
ATC
valproic acid; systemic, rectal
0.7
7.3
191
1984
TJF80
NOMESCO Finland
Ostomy education
2.1
7.3
82
276
P20
ICPC
Memory disturbance
1.2
7.3
821
4706
N05AH03
ATC
olanzapine; systemic
0.6
7.3
153
1659
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
1.7
7.3
157
666
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.2
7.3
1413
8555
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
0.3
7.2
17
374
4194
NOMESCO Finland
NA
13.1
7.2
13
7
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
1.9
7.2
107
403
H02
ICPC
Hearing complaint
1.2
7.2
839
4824
YN2AS
NOMESCO Finland
NA
+∞
7.2
8
*
JR2PR
NOMESCO Finland
NA
+∞
7.2
8
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
1.5
7.2
227
1059
D16
ICPC
Rectal bleeding
1.8
7.2
118
460
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.2
7.2
1778
10975
WC205
NOMESCO Finland
Simple therapy of local tumor recidive with hormone
63.3
7.2
9
*
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
63.3
7.2
9
*
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
1.4
7.2
361
1847
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.1
7.1
2411
15229
KH1AD
NOMESCO Finland
CT of urinary organs
1.4
7.1
281
1376
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
3.5
7.1
33
67
H02AB06
ATC
prednisolone; systemic
1.1
7.1
3956
25783
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.4
7.1
388
2013
KED33
NOMESCO Finland
Transurethral incision of prostate
1.6
7.0
182
809
G04BXXX
ATC
NA
19.3
7.0
11
*
I50.1
ICD-10 Finland
Left ventricular failure
0.7
7.0
325
3071
SPAT1310
SPAT
Counselling related to known health issue
1.1
7.0
2213
13913
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.2
6.9
750
4282
R30.0
ICD-10 Finland
Dysuria
1.6
6.9
187
842
188
Kela drug reimbursment
Psychosis requiring demanding treatment
0.2
6.9
7
243
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.2
6.8
987
5811
L04AX01
ATC
azathioprine; systemic
0.6
6.8
115
1304
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
5.8
6.8
19
23
H26.4
ICD-10 Finland
After-cataract
1.3
6.8
532
2916
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.2
6.7
802
4628
N13.9
ICD-10 Finland
Obstructive and reflux uropathy, unspecified
2.5
6.7
53
152
N05AA01
ATC
chlorpromazine; systemic, rectal
0.4
6.7
27
474
H13
ICPC
Plugged feeling ear
1.2
6.7
1370
8328
R42
ICD-10 Finland
Dizziness and giddiness
1.2
6.7
1454
8885
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
0.6
6.7
101
1175
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
1.4
6.7
276
1366
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
1.8
6.6
115
458
Z43.5
ICD-10 Finland
Attention to cystostomy
2.2
6.6
63
198
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.4
6.6
315
1600
Z94.0
ICD-10 Finland
Kidney transplant status
0.4
6.6
21
401
XA800
NOMESCO Finland
Neuropsychological investigation
0.6
6.6
132
1440
H3601, E113
ICD-10 Finland
NA
0.5
6.5
48
678
B01AB04
ATC
dalteparin; parenteral
1.4
6.5
319
1629
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.3
6.4
563
3133
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
3.7
6.4
27
51
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
0.5
6.4
59
781
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
0.5
6.4
48
674
127
Kela drug reimbursment
Transplant complication
0.5
6.4
41
603
ZX001
NOMESCO Finland
Simple adjustment of radiotherapy with simulator or with therapeutic device - SSD therapy
56.3
6.3
8
*
C61, C795
ICD-10 Finland
NA
+∞
6.3
7
*
3031
Kela drug reimbursment
Apalutamidi
+∞
6.3
7
*
R33, C61
ICD-10 Finland
NA
+∞
6.3
7
*
K59.0
ICD-10 Finland
Constipation
1.4
6.3
362
1897
L82
ICD-10 Finland
Seborrhoeic keratosis
1.2
6.3
968
5732
G04BX08
ATC
NA
1.8
6.3
103
404
N05AX12
ATC
aripiprazole; systemic
0.5
6.3
35
544
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.3
6.3
423
2270
N05AF03
ATC
chlorprothixene; systemic
0.6
6.2
69
866
A10AE04
ATC
insulin glargine; parenteral
0.8
6.2
574
4975
N13.8
ICD-10 Finland
Other obstructive and reflux uropathy
4.9
6.2
20
29
F10.20
ICD-10 Finland
Alcohol dependence currently independent
0.6
6.1
69
863
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
1.9
6.1
90
340
ZX136
NOMESCO Finland
Intravesicalis
2.0
6.1
72
251
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
1.5
6.1
228
1106
E66.01
ICD-10 Finland
Obesity due to excess calories
0.7
6.1
201
2001
I42.0
ICD-10 Finland
Dilated cardiomyopathy
0.7
6.1
145
1530
L04AB04
ATC
adalimumab; parenteral
0.4
6.1
22
401
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
0.4
6.1
18
356
S55
ICPC
Skin, Local injection/infiltration
3.7
6.0
25
47
S82
ICPC
Naevus/mole
1.2
6.0
641
3655
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
6979
28570
1.86
314.06
4.0
3.4
0.3
0.5
e6/l
5.52
5831
21805
8173
34427
1.88
307.65
4.6
3.9
99.7
107.7
e6/l
0.24
6854
25975
13384
57520
2.61
307.65
5.3
4.3
583.9
699.1
e6/l
0.13
276
1090
14442
69591
2.32
307.65
9.8
7.9
83.7
80.8
u/l
4.36
13904
65191
9807
40694
2.08
307.65
4.8
2.8
1.1
0.7
ug/l
48.36
7573
28781
5815
21824
1.99
307.65
3.0
2.8
2.6
2.9
e6/l
1.74
5231
19096
15670
72849
3.10
307.65
12.1
4.0
10.7
2.4
ug/l
28.43
13783
65024
4954
9663
4.03
307.65
2.1
2.1
7.3
14.7
nmol/l
307.65
4195
8437
12688
57936
2.17
307.65
8.1
3.9
15.4
23.9
%
307.65
8661
28991
7822
31389
1.98
307.65
4.1
3.5
155.6
124.3
e6/l
0.50
6662
24625
6574
28663
1.69
217.46
4.5
3.3
2.3
2.3
mmol/l
5.51
5834
24448
10043
49250
1.61
205.02
7.6
6.6
11.8
13.5
umol/l
37.56
9628
46848
9028
43389
1.60
197.19
4.5
4.4
—
—
—
0
0
4191
16738
1.75
184.40
3.9
3.2
0.6
0.8
e6/l
3.82
2724
9612
4209
17904
1.62
140.50
3.6
3.0
0.9
1.0
e6/l
0.45
2732
10701
9395
47779
1.48
137.90
7.9
7.7
1.2
1.2
mmol/l
8.04
7757
40296
724
1715
2.73
118.22
2.3
1.7
23.4
25.1
ug/l
0.27
711
1680
8587
43793
1.44
116.14
6.8
7.0
1.2
1.2
mmol/l
10.38
7733
39599
1756
6176
1.88
112.17
3.6
3.0
0.2
0.3
e6/l
2.60
1732
6097
15193
86632
1.55
112.10
19.1
18.3
30.9
30.0
mg/l
2.02
12834
71817
14469
81821
1.50
108.29
20.6
17.0
73.4
74.5
ml/min/173m2
8.43
12737
68163
15967
92372
1.59
105.94
22.7
21.7
139.5
139.6
mmol/l
3.35
15576
90024
15977
92558
1.58
103.39
22.9
21.9
4.0
4.0
mmol/l
3.84
15566
90108
15900
92273
1.56
97.64
25.2
21.4
92.3
92.1
umol/l
0.17
15890
92225
8287
42843
1.39
97.17
3.9
3.5
0.0
0.0
estimate
1.88
1896
7514
9585
50919
1.38
94.38
9.3
9.0
4.4
4.5
e9/l
4.88
8383
44012
8152
42229
1.38
92.97
5.0
4.6
0.0
0.0
estimate
0.50
1974
8075
478
1038
2.96
90.97
2.7
3.9
7.1
9.7
nmol/l
0.57
471
1018
10850
59087
1.37
89.52
4.9
5.6
6.9
7.0
mmol/l
13.22
10319
55872
8169
42508
1.38
89.37
3.9
3.5
0.0
0.0
estimate
0.50
1936
7819
16119
94454
1.53
84.54
29.9
26.1
228.0
227.2
e9/l
0.83
15737
91316
16122
94494
1.53
84.16
29.9
26.1
6.9
7.1
e9/l
24.16
15688
90972
16120
94488
1.53
83.99
29.9
26.1
4.4
4.5
e12/l
134.52
15673
90918
16121
94500
1.53
83.89
30.1
26.2
133.3
137.4
g/l
169.06
15873
92630
6485
32771
1.38
82.98
4.2
3.8
—
—
—
0
0
15708
91845
1.47
78.71
12.4
11.3
25.8
27.9
u/l
16.67
15055
87950
8721
46422
1.35
78.68
11.3
11.7
1.3
1.4
inr
3.65
2599
12379
8053
42689
1.33
72.44
5.0
5.4
34.2
34.3
g/l
0.41
7425
39599
4881
24092
1.38
69.14
4.2
3.9
0.0
0.0
estimate
0.38
1783
7246
4699
23585
1.34
57.75
2.7
2.7
—
—
—
0
0
3481
16705
1.39
56.65
3.6
3.3
2.5
2.4
mmol/l
4.29
3059
14446
5079
26002
1.32
53.69
2.2
2.3
3.0
3.0
mg/l
0.28
4253
22008
1797
7829
1.50
48.63
4.7
4.3
1.2
1.2
mmol/l
0.67
1570
6881
2331
10818
1.41
45.08
3.9
3.8
—
—
—
0
0
12792
74525
1.26
42.75
21.5
19.3
38.3
39.6
%
26.45
7636
46670
6234
33742
1.25
39.31
2.8
3.0
242.3
196.4
ug/l
9.15
5513
30680
11842
69005
1.22
35.10
25.3
21.6
13.9
13.9
%
0.11
11648
67322
7083
39311
1.22
33.73
12.2
10.8
0.0
0.0
e9/l
0.00
5887
32202
4572
24233
1.25
33.47
1.7
1.6
18.4
19.0
nmol/l
1.61
3873
20865
14320
85304
1.25
33.32
5.2
5.2
6.1
6.2
mmol/l
15.49
12500
76690
11076
64291
1.21
32.98
3.9
4.1
15.0
13.5
mm/h
14.08
9967
58875
7668
43291
1.20
29.11
5.5
6.3
23.8
25.2
%
21.56
7042
40047
14488
87105
1.21
25.38
5.3
5.5
2.5
2.5
mmol/l
6.36
12787
79355
7456
42370
1.18
24.92
5.3
6.2
2.9
2.9
%
0.00
6883
39360
7486
42576
1.18
24.71
5.3
6.1
60.3
59.1
%
12.36
6923
39601
13823
82949
1.19
23.16
6.6
7.0
40.7
41.5
mmol/mol
17.56
12367
75856
14114
84916
1.20
22.54
4.8
4.9
4.3
4.2
mmol/l
18.20
12522
77786
12590
75057
1.18
22.06
3.8
3.9
2.2
2.2
mu/l
0.16
10871
66790
13980
84109
1.19
21.84
4.8
4.9
1.3
1.3
mmol/l
40.39
12305
76358
2743
14348
1.24
21.27
4.4
4.2
252.6
244.1
u/l
1.40
2582
13562
7134
40796
1.17
20.80
4.2
4.2
57.3
84.2
ng/l
2.46
5871
32545
7234
41511
1.16
19.87
2.1
2.1
92.2
90.5
pmol/l
2.45
4141
24156
2334
12125
1.25
19.10
4.8
4.9
31.9
31.8
%
0.05
1503
8347
13566
81717
1.17
18.94
4.2
4.4
1.3
1.3
mmol/l
8.19
11812
73691
4496
24963
1.18
18.37
4.2
4.5
82.9
80.3
%
9.69
4417
24442
3862
21176
1.19
18.24
1.9
1.8
1130.2
1134.3
nmol/l
0.10
2823
16082
6064
34540
1.16
17.81
3.1
3.3
2017.4
1838.8
ng/l
1.42
5234
30360
329
1217
1.72
17.54
1.4
1.2
—
—
—
0
0
2140
11187
1.23
16.39
3.8
4.3
20.5
32.1
ug/l
1.44
1776
9531
3501
19201
1.19
16.24
4.4
3.9
1.0
1.0
kg/l
0.52
572
2892
3410
18673
1.19
16.08
1.9
1.9
—
—
—
0
0
235
821
1.82
15.26
1.4
1.2
106.5
56.4
u/l
1.66
174
509
2679
14473
1.20
14.58
2.4
2.5
1.7
1.7
%
0.22
2322
12735
3186
17574
1.17
13.52
2.5
2.8
12.2
12.5
umol/l
1.63
2915
16291
7857
46191
1.13
13.10
5.2
5.9
1.7
1.9
e9/l
15.37
6739
40102
7917
46665
1.12
12.38
5.3
6.1
0.2
0.2
e9/l
4.19
6769
40426
2986
16495
1.17
12.33
2.5
2.8
2.2
2.2
g/l
4.47
2723
15280
5313
30609
1.13
12.05
2.0
2.1
79.3
76.1
nmol/l
11.86
4524
26773
2768
15236
1.17
11.92
6.6
7.7
104.9
104.6
mmol/l
2.32
2712
14855
2045
10979
1.20
11.78
2.7
2.6
66.2
67.5
e9/l
1.06
1582
8505
5275
30493
1.13
11.14
2.5
2.7
59.0
60.7
u/l
0.76
4837
28253
1513
7943
1.22
10.99
3.2
4.2
0.1
0.1
%
0.03
498
2574
3784
21437
1.14
10.93
1.9
1.7
21037195.2
29309568.2
pmol/l
0.51
2990
17544
142
473
1.90
10.84
1.9
1.5
6.4
6.7
u/l
0.07
76
217
4964
28641
1.13
10.74
3.5
3.3
35.6
37.8
u/l
0.98
4668
26954
2813
15621
1.16
10.73
2.6
2.8
22.6
22.8
%
0.21
2347
13270
1228
9411
0.81
10.53
1.7
1.8
1.7
1.7
%
0.02
1002
7844
956
4794
1.27
10.49
2.0
2.0
—
—
—
0
0
556
2594
1.36
10.22
2.4
2.7
15.7
16.3
%
3.00
309
1419
8991
53735
1.11
10.08
3.2
3.3
58.3
64.0
u/l
4.85
8110
49198
882
4406
1.28
9.99
1.8
1.8
—
—
—
0
0
432
3755
0.72
9.80
1.6
1.7
45.9
45.5
nmol/l
0.12
419
3583
575
2726
1.34
9.56
4.1
4.8
2.4
2.5
mmol/l
0.31
366
1831
575
2727
1.34
9.54
4.1
4.8
4.9
5.0
kpa
0.47
560
2658
1429
7565
1.21
9.54
3.1
4.0
1.1
0.6
%
3.82
370
1995
123
416
1.87
9.05
1.2
1.1
76.9
103.2
u/l
1.98
78
337
123
416
1.87
9.05
1.2
1.1
22.6
34.7
u/l
1.28
73
321
1313
6940
1.21
8.91
1.8
1.7
—
—
—
0
0
1298
6876
1.21
8.61
7.7
10.6
—
—
—
0
0
1438
7764
1.18
7.74
3.4
3.9
1.6
1.6
mmol/l
0.06
1021
5677
1049
5505
1.21
7.69
2.0
2.0
3.1
2.1
ug/l
0.90
901
4876
1500
8140
1.18
7.60
3.5
4.0
5.1
5.1
kpa
1.28
1373
7511
125
455
1.74
7.35
1.7
1.2
105.7
108.2
u/l
0.07
112
387
99
1096
0.57
7.19
1.4
1.2
1.5
1.4
nmol/l
0.82
90
989
120
436
1.74
7.12
1.7
1.2
37.0
28.9
u/l
0.60
106
369
6674
39761
1.09
7.09
2.1
2.1
—
—
—
0
0
147
566
1.64
7.07
1.7
1.8
2.4
2.7
u/field
0.25
97
399
200
830
1.53
7.03
1.8
1.9
2.2
1.7
u/field
0.48
89
333
1366
7422
1.17
6.83
1.6
1.7
—
—
—
0
0
36
548
0.41
6.78
5.4
5.5
35.0
1624.0
u/ml
—
5
105
24
437
0.35
6.78
1.1
1.3
—
—
—
0
0
290
1308
1.41
6.70
2.0
2.2
28.8
28.6
mg/l
0.02
77
358
294
2540
0.73
6.56
1.2
1.4
—
—
—
0
0
12
307
0.25
6.42
17.2
15.9
1538.7
1328.1
nmol/l
0.50
12
291
579
2916
1.26
6.28
2.7
3.1
7.8
7.8
kpa
0.13
540
2692
393
1883
1.32
6.24
1.8
2.0
1.9
1.8
mmol/l
0.96
384
1832
11
291
0.24
6.23
13.0
11.2
1050.4
813.4
nmol/l
0.58
11
271
293
2511
0.73
6.23
1.5
1.6
19.4
7.9
iu/ml
0.31
75
604
263
2283
0.72
6.08
1.3
1.4
1.0
0.8
nmol/l
1.82
219
1885
271
2341
0.73
6.08
1.2
1.3
—
—
—
0
0
1478
8160
1.16
6.03
3.3
3.0
62.0
61.0
ml/min/173m2
0.38
609
3370
241
2086
0.73
5.52
1.5
1.3
8.6
7.4
u/l
0.94
179
1681
401
1966
1.29
5.45
2.8
3.8
2.1
1.5
%
1.79
283
1519
935
5043
1.18
5.18
4.4
5.6
0.9
0.9
%
0.13
860
4747
245
2080
0.74
4.98
1.3
1.3
—
—
—
0
0
2999
17469
1.10
4.96
3.0
3.6
0.8
0.8
mmol/l
0.27
2808
16296
9407
57335
1.07
4.93
3.0
3.1
15.1
15.0
pmol/l
1.88
8098
50631
336
2716
0.78
4.78
1.8
1.8
169.6
196.5
pmol/l
3.50
303
2510
184
1620
0.71
4.75
1.4
1.5
114.0
115.9
u/ml
0.09
48
364
1108
6111
1.15
4.64
1.5
1.7
1.6
1.5
g/l
2.86
933
5197
535
2772
1.22
4.60
2.2
2.3
124.8
130.8
g/l
5.42
410
2020
943
5151
1.16
4.50
4.4
5.5
1.6
1.7
%
2.35
867
4855
292
2382
0.77
4.49
1.7
1.7
10.9
12.0
mg/l
1.37
261
2229
904
4925
1.17
4.47
3.8
4.4
24.6
24.6
mmol/l
0.13
821
4524
434
2222
1.24
4.21
3.5
3.6
33.5
31.5
mg/l
0.47
279
1478
3874
22987
1.08
4.13
1.6
1.7
1.3
1.3
mmol/l
2.74
3043
18845
28
380
0.46
4.09
1.1
2.1
—
—
—
0
0
162
1416
0.72
4.07
1.5
1.7
1.0
1.0
g/l
0.15
122
1066
1640
11419
0.90
4.00
2.3
2.5
6.8
8.4
ug/l
2.91
1386
10085
2232
12951
1.10
3.99
1.8
1.8
—
—
—
0
0
525
2758
1.21
3.99
5.5
7.5
104.9
105.2
mmol/l
0.60
458
2508
156
1366
0.72
3.97
3.4
4.3
316.1
338.9
umol/l
1.44
121
1140
637
3412
1.18
3.92
2.9
3.3
24.3
24.5
mmol/l
0.34
566
2991
591
4403
0.84
3.90
1.9
2.0
—
—
—
0
0
152
1332
0.72
3.89
2.5
2.4
—
0.7
—
0
12
346
2710
0.80
3.84
1.6
1.6
19244.1
16043.6
e6/l
0.51
232
1994
48
531
0.57
3.70
24.4
30.6
110.3
113.8
ug/l
0.17
43
454
376
2906
0.81
3.70
1.9
2.6
29.6
34.3
umol/l
4.92
302
2423
1893
10940
1.10
3.69
2.7
3.0
9.1
11.5
umol/l
3.83
1673
9781
1797
10361
1.10
3.67
2.8
3.2
262.1
268.3
ng/l
0.15
1643
9538
98
909
0.68
3.51
1.1
1.1
3.1
1.8
iu/ml
—
8
46
2912
17195
1.08
3.49
29.5
30.0
1.5
1.5
inr
0.13
444
2269
462
3475
0.84
3.45
2.3
2.4
122.1
131.7
ug/min
0.15
246
2104
248
1222
1.28
3.41
2.7
3.7
62.1
59.6
%
0.74
140
786
501
3734
0.84
3.38
1.6
1.7
37.6
37.4
u/l
0.06
415
3176
525
3894
0.85
3.34
4.5
4.9
4.0
4.0
mmol/l
0.05
476
3647
2213
12959
1.09
3.25
1.8
1.8
—
—
—
0
0
15
234
0.40
3.21
2.0
2.7
123.6
134.8
nmol/l
0.24
15
202
185
1524
0.76
3.19
1.1
1.1
63.8
188.1
iu/ml
0.52
38
290
252
1990
0.80
3.10
1.4
1.7
2.9
4.4
mg/l
2.44
188
1417
630
4570
0.87
3.04
4.1
4.6
1.4
1.4
mmol/l
0.67
613
4479
233
1852
0.79
3.04
1.3
1.3
39.0
28.6
e6/l
0.14
167
1465
312
1607
1.23
2.99
2.6
2.6
105.9
105.7
mmol/l
0.30
306
1595
312
1607
1.23
2.99
2.6
2.6
4.1
4.1
mmol/l
0.73
306
1596
234
1853
0.79
2.96
1.4
1.4
502.5
2639.7
e6/l
1.14
179
1540
2041
11961
1.09
2.96
6.9
8.7
120.9
122.6
g/l
3.19
1950
11568
2267
13350
1.08
2.92
6.6
8.0
95.5
95.2
%
1.33
2147
12881
284
2193
0.81
2.86
1.2
1.2
127.4
118.9
titre
0.06
27
185
5624
36884
0.95
2.86
4.0
4.2
9.4
10.5
mg/mmol
0.94
3622
25455
114
516
1.40
2.83
3.3
2.9
210.4
210.5
u/l
0.01
114
509
25
306
0.52
2.81
1.1
1.1
—
—
—
0
0
178
1445
0.78
2.80
1.2
1.2
281.1
290.7
u/ml
0.18
111
904
311
2373
0.82
2.79
1.2
1.4
1.2
1.2
g/l
0.05
297
2250
321
2439
0.83
2.76
1.1
1.2
0.2
0.6
u/ml
2.27
27
231
44
457
0.61
2.75
1.2
2.0
—
—
—
0
0
168
1369
0.77
2.73
1.8
1.8
281.2
271.8
mu/l
0.19
160
1279
673
4816
0.88
2.70
1.6
1.5
16.6
17.1
u/ml
0.02
13
115
137
1144
0.75
2.68
1.4
1.3
133476.2
145982.6
e6/l
0.09
97
800
301
2294
0.83
2.68
1.2
1.4
0.2
0.2
g/l
0.57
284
2168
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
857
4846
1.12
2.59
2.7
2.9
0.3
0.3
u/ml
0.58
491
2763
84
752
0.70
2.58
1.1
1.2
81.7
140.7
titre
1.31
18
127
88
388
1.43
2.56
2.1
2.5
—
—
—
0
0
88
388
1.43
2.56
2.1
2.5
—
—
—
0
0
37
393
0.59
2.56
1.4
1.3
70.7
62.5
%
0.86
32
338
1197
6901
1.10
2.53
7.9
9.6
23.8
24.2
mmol/l
4.10
1123
6363
1828
10743
1.08
2.50
6.3
7.4
1.4
1.4
mmol/l
1.06
1744
10302
1169
6740
1.10
2.47
1.5
1.5
—
—
—
0
0
5327
34872
0.95
2.46
3.2
3.5
348.1
349.6
mg/l
0.01
3475
24448
2458
14624
1.07
2.42
6.4
7.7
0.6
1.0
mmol/l
5.04
1870
11415
232
1190
1.23
2.39
1.4
1.5
—
—
—
0
0
60
561
0.67
2.37
1.1
1.2
—
—
—
0
0
33
117
1.78
2.36
1.1
1.1
10.5
19.5
iu/ml
0.69
12
44
50
480
0.66
2.27
1.5
2.2
1013.8
4805.1
e6/l
1.06
38
347
476
2620
1.15
2.24
3.7
3.7
7.4
7.9
mmol/l
4.18
466
2571
1717
10118
1.08
2.22
2.6
2.6
65.7
66.3
g/l
2.45
1521
9260
95
810
0.74
2.22
1.1
1.1
—
—
—
0
0
43
423
0.64
2.20
1.4
2.1
20972.5
7531.9
e6/l
0.55
28
246
519
3719
0.88
2.19
1.6
1.6
91.5
248.9
titre
3.80
23
152
5366
35032
0.95
2.18
3.1
3.4
8.1
8.3
mmol/l
3.52
4228
29118
194
989
1.24
2.15
1.5
1.5
—
—
—
0
0
75
659
0.72
2.13
1.1
1.1
—
—
—
0
0
227
1179
1.22
2.12
1.4
1.5
—
—
—
0
0
227
1179
1.22
2.12
1.4
1.5
—
—
—
0
0
201
1551
0.82
2.11
1.2
1.2
—
—
—
0
0
1215
7077
1.09
2.10
5.9
7.8
24.4
24.6
mmol/l
1.04
1201
7006
293
2182
0.85
2.10
1.5
1.6
—
—
—
0
0
567
3177
1.13
2.07
1.3
1.3
—
—
—
0
0
496
2757
1.14
2.05
3.7
3.6
1.6
1.7
mmol/l
0.48
486
2698
234
1225
1.21
2.03
1.4
1.5
—
—
—
0
0
36
361
0.63
2.03
3.2
2.8
26.0
29.7
umol/l
2.10
31
276
550
3904
0.89
2.03
1.3
1.3
483.3
317.4
u/ml
0.84
507
3610
3014
18152
1.06
2.02
1.9
2.1
30.4
30.4
s
0.09
2923
17632
195
1499
0.82
2.00
1.1
1.1
4.8
10.3
u/ml
0.83
14
124
7
112
0.39
1.97
1.0
1.0
—
—
—
0
0
225
1178
1.21
1.97
1.4
1.5
—
—
—
0
0
977
6716
0.91
1.96
2.5
2.7
10.8
11.0
g/l
0.64
862
6167
164
1280
0.81
1.95
1.1
1.1
1.5
1.6
g/l
0.44
146
1164
44
417
0.67
1.93
1.0
1.1
0.7
3.0
u/ml
2.66
14
170
225
1694
0.84
1.87
2.0
2.8
639.2
6233.3
u/ml
0.69
17
125
227
1197
1.20
1.86
1.4
1.5
—
—
—
0
0
38
365
0.66
1.80
1.4
1.5
12.7
13.3
g/l
0.19
27
279
141
711
1.25
1.78
1.4
1.5
—
—
—
0
0
41
387
0.67
1.78
1.0
1.0
0.6
2.8
u/ml
2.10
14
148
73
622
0.74
1.77
2.2
2.0
—
—
—
0
0
41
386
0.67
1.76
1.1
1.0
—
—
—
0
0
703
4030
1.11
1.76
3.1
3.6
1215.2
2117.8
u/ml
0.54
595
3538
154
1193
0.81
1.75
1.9
2.3
747.8
696.8
ml
0.65
82
779
302
2203
0.86
1.73
3.5
6.1
4130.6
1314.6
iu/ml
0.32
37
375
59
263
1.42
1.73
1.4
1.8
4.6
6.2
nmol/l
0.29
53
233
160
1232
0.82
1.72
1.1
1.1
—
—
—
0
0
964
5618
1.09
1.71
4.1
4.4
23.7
23.9
mmol/l
0.96
865
5006
33
130
1.60
1.70
2.8
2.7
0.2
0.2
u/field
0.10
33
130
142
723
1.24
1.67
1.4
1.4
—
—
—
0
0
140
712
1.24
1.67
1.4
1.5
—
—
—
0
0
267
1445
1.17
1.66
6.4
12.8
7.3
7.5
mmol/l
0.66
222
1174
3054
18499
1.05
1.66
1.6
1.7
1.8
1.6
mg/l
1.89
2404
14688
139
708
1.24
1.64
1.4
1.4
—
—
—
0
0
36
341
0.67
1.62
1.4
1.3
9.9
13.3
u/l
1.06
27
277
2431
14649
1.05
1.62
6.4
7.7
12.0
11.7
kpa
1.81
2285
13951
2432
14660
1.05
1.60
6.5
7.7
5.1
5.1
kpa
0.26
2282
13973
25
255
0.62
1.59
1.4
1.3
—
—
—
0
0
85
409
1.31
1.58
5.4
5.8
36.2
73.4
u/ml
0.64
29
122
69
581
0.75
1.58
1.6
1.7
0.9
0.9
g/l
0.31
69
575
33
315
0.66
1.56
1.4
1.2
1.6
1.4
mmol/l
0.64
21
203
5178
31775
1.04
1.55
2.2
2.3
237.8
257.6
u/l
0.84
4834
29782
35
330
0.67
1.55
1.0
1.0
0.3
0.2
u/ml
0.17
12
92
2503
15114
1.05
1.55
5.6
6.7
1.0
1.0
mmol/l
0.38
2309
14114
295
2132
0.87
1.52
1.3
1.3
602.3
609.7
mg/l
0.08
273
2028
413
2921
0.89
1.52
2.7
2.9
1.9
1.8
mg/l
2.70
365
2625
103
818
0.79
1.51
1.0
1.0
318.4
312.6
ng/l
0.06
76
556
14
44
2.01
1.48
1.4
1.5
79.0
136.3
ug/l
—
7
30
105
829
0.80
1.47
1.2
1.1
206.8
163.7
miu/ml
0.31
19
161
119
605
1.24
1.46
1.6
2.0
—
—
—
0
0
104
820
0.80
1.45
1.0
1.0
38.7
41.3
ng/l
0.29
76
545
104
820
0.80
1.45
1.0
1.0
703.8
715.6
ng/l
0.11
73
541
87
700
0.78
1.44
1.1
1.2
—
—
—
0
0
42
183
1.45
1.43
1.6
1.7
80.7
111.2
ug/l
1.42
34
150
258
1871
0.87
1.42
1.2
1.3
3.8
4.0
mmol/l
1.52
238
1758
119
608
1.24
1.41
1.6
2.0
—
—
—
0
0
119
608
1.24
1.41
1.6
2.0
—
—
—
0
0
119
608
1.24
1.41
1.6
2.0
—
—
—
0
0
58
491
0.74
1.41
1.0
1.1
1.0
1.5
u/ml
0.24
13
112
1916
12685
0.95
1.38
1.5
1.5
2.7
3.0
g/l
5.02
1117
7719
85
679
0.79
1.35
1.1
1.1
0.4
1.6
u/ml
2.71
35
282
78
629
0.78
1.34
1.2
1.2
1.3
1.2
nmol/l
0.10
63
466
99
499
1.25
1.34
1.5
1.5
2.6
4.4
%
1.17
21
123
95
478
1.26
1.31
1.7
2.2
—
—
—
0
0
18
65
1.75
1.31
1.1
1.1
1.2
1.0
u/field
0.34
13
42
1997
13184
0.95
1.31
1.2
1.2
1.7
2.1
u/ml
0.89
486
3295
11
132
0.53
1.30
1.8
2.3
—
191.3
—
0
18
61
505
0.76
1.29
1.6
1.4
8.2
6.6
u/l
0.24
50
427
105
813
0.81
1.27
1.1
1.2
—
—
—
0
0
23
90
1.61
1.27
3.1
1.5
—
—
—
0
0
244
1346
1.15
1.25
1.4
1.7
—
—
—
0
0
157
837
1.19
1.25
1.4
1.5
—
—
—
0
0
19
193
0.62
1.24
2.8
5.0
46.8
47.3
u/l
—
5
70
120
913
0.83
1.23
1.5
1.4
—
—
—
0
0
127
961
0.83
1.23
1.5
2.0
746.7
3429.3
titre
—
6
45
14
153
0.58
1.22
6.0
5.0
—
—
—
0
0
5
72
0.44
1.17
10.6
5.6
—
—
—
0
0
443
3065
0.91
1.15
1.3
1.4
7.8
11.2
iu/ml
—
7
62
93
476
1.23
1.14
1.7
2.2
—
—
—
0
0
20
78
1.62
1.14
1.1
1.4
—
—
—
0
0
488
2821
1.09
1.14
1.4
1.7
—
—
—
0
0
668
4537
0.93
1.12
2.4
2.4
622.4
630.1
ug/l
0.02
646
4331
93
477
1.23
1.12
1.7
2.2
—
—
—
0
0
435
3008
0.91
1.12
1.9
2.4
3.9
3.7
g/l
1.81
407
2883
714
4197
1.08
1.12
2.8
3.4
68.5
45.5
mg/l
0.62
556
3416
435
2504
1.10
1.11
1.4
1.4
—
—
—
0
0
435
2505
1.10
1.11
1.4
1.4
—
—
—
0
0
695
4086
1.08
1.09
2.8
3.4
3.5
5.6
ratio
0.56
58
311
134
996
0.85
1.09
1.4
1.3
49.2
103.0
pmol/l
1.04
71
303
6
81
0.47
1.08
1.0
1.0
—
—
—
0
0
1416
8520
1.05
1.07
2.3
2.6
34.3
53.8
u/l
1.39
1186
7323
327
1862
1.11
1.05
1.3
1.3
—
—
—
0
0
188
1035
1.15
1.04
1.4
1.3
0.2
0.3
nmol/l
0.64
21
103
128
950
0.85
1.03
1.4
1.8
4.0
4.4
mg/l
0.54
116
904
102
772
0.83
1.03
1.1
1.2
90.1
95.6
%
1.29
90
712
93
709
0.83
1.02
2.1
2.3
66.3
144.8
ug/min
1.23
30
170
187
1032
1.15
1.01
1.4
1.3
0.7
1.8
nmol/l
0.59
179
989
13
136
0.60
1.00
1.2
1.4
75.5
70.7
%
1.18
13
128
13
136
0.60
1.00
1.2
1.4
371.7
1937.6
mu/l
1.12
13
128
711
4204
1.07
0.98
2.8
3.4
73.3
63.9
mg/l
0.43
549
3419
13
47
1.75
0.97
1.2
1.5
1.4
0.9
u/field
—
7
24
364
2095
1.10
0.97
1.5
1.8
—
—
—
0
0
17
67
1.60
0.95
1.3
1.1
—
—
—
0
0
59
467
0.80
0.94
1.1
1.1
—
—
—
0
0
59
467
0.80
0.94
1.1
1.1
—
—
—
0
0
94
709
0.84
0.94
1.0
1.1
—
—
—
0
0
220
1235
1.13
0.94
2.4
3.0
—
—
—
0
0
503
2943
1.08
0.93
1.4
1.6
—
—
—
0
0
132
967
0.86
0.93
1.1
1.1
107.0
108.9
%
0.31
111
874
400
2747
0.92
0.93
1.4
1.5
259.3
245.1
ug/g
0.69
249
1697
1876
11408
1.04
0.93
4.0
4.2
1.6
1.7
mmol/l
0.60
1486
9174
467
2725
1.08
0.93
1.4
1.7
—
—
—
0
0
673
3982
1.07
0.93
2.4
2.6
1.4
1.1
g/l
0.51
551
3389
5
65
0.49
0.92
1.4
1.3
—
—
—
0
0
34
157
1.37
0.92
1.5
1.2
72.8
128.6
u/ml
0.63
29
148
60
470
0.81
0.89
1.1
1.1
—
—
—
0
0
60
470
0.81
0.89
1.1
1.1
—
—
—
0
0
60
469
0.81
0.88
1.1
1.1
—
—
—
0
0
133
726
1.16
0.87
3.6
3.5
—
—
—
0
0
38
314
0.76
0.87
1.5
1.9
15.6
571.9
ug/l
1.00
38
297
789
4706
1.06
0.86
2.1
2.4
—
—
—
0
0
6
73
0.52
0.86
1.2
1.3
—
—
—
0
0
21
90
1.47
0.85
1.1
1.0
—
—
—
0
0
789
4709
1.06
0.85
2.1
2.4
7.4
7.3
g/l
0.86
550
3495
26
226
0.73
0.84
1.3
1.3
0.3
0.3
g/l
0.38
19
179
467
3170
0.93
0.84
1.4
1.4
—
—
—
0
0
11
114
0.61
0.84
1.0
1.0
—
—
—
0
0
1606
9761
1.04
0.84
2.1
2.4
0.2
0.2
g/l
0.50
1467
8972
1873
11420
1.04
0.84
4.0
4.1
5.8
5.8
kpa
0.99
1828
11053
786
4694
1.06
0.83
2.1
2.4
4.0
3.9
g/l
0.66
531
3364
736
4389
1.06
0.82
2.1
2.4
10.2
10.5
g/l
0.85
584
3705
1196
7226
1.05
0.82
2.1
2.3
166.1
183.0
ug/g
0.64
902
5735
0
16
0.00
0.82
0.0
6.1
—
0.4
—
0
16
68
352
1.22
0.82
1.9
1.7
-0.2
0.1
mmol/l
0.23
63
330
16
151
0.67
0.81
1.1
1.1
—
—
—
0
0
371
2537
0.92
0.81
1.1
1.1
159.1
212.3
titre
0.40
11
66
286
1978
0.91
0.81
1.6
1.7
—
—
—
0
0
48
239
1.27
0.81
2.2
2.7
6.9
8.3
mmol/l
2.30
35
144
6
20
1.89
0.81
1.0
1.2
2.2
3.1
%
—
6
20
5
63
0.50
0.80
2.2
2.3
—
—
—
0
0
1132
6835
1.05
0.80
3.9
4.7
107.2
110.1
ng/l
0.35
948
5947
121
663
1.15
0.78
1.3
1.2
2.3
2.2
mmol/l
0.28
111
620
1569
10270
0.96
0.78
1.2
1.2
11.1
15.6
u/ml
1.43
486
3616
37
301
0.78
0.78
2.6
2.7
—
—
—
0
0
12
46
1.65
0.76
2.8
3.1
178.3
27.8
pmol/l
—
7
29
17
156
0.69
0.76
1.5
2.4
—
—
—
0
0
342
2337
0.92
0.76
1.6
1.6
—
—
—
0
0
1711
11171
0.96
0.75
1.2
1.2
34.1
42.5
iu/ml
1.38
464
3300
84
623
0.85
0.74
1.0
1.1
286.8
279.0
mg/l
0.56
76
566
158
886
1.13
0.74
1.4
1.3
—
—
—
0
0
340
1983
1.08
0.74
1.4
1.4
—
—
—
0
0
30
142
1.33
0.73
2.2
2.1
—
—
—
0
0
30
142
1.33
0.73
2.1
2.1
—
—
—
0
0
103
751
0.87
0.73
1.1
1.2
80.2
36.1
u/ml
—
5
40
25
212
0.74
0.72
1.4
1.3
119.5
111.7
%
0.46
20
190
34
275
0.78
0.70
1.0
1.1
—
7.2
u/ml
—
0
21
3423
21146
1.03
0.70
4.0
4.3
643.4
698.2
ng/l
0.08
2989
18589
105
761
0.87
0.70
1.1
1.1
6.6
8.4
au/ml
—
7
31
147
1041
0.89
0.69
1.2
1.2
3.5
4.0
u/ml
0.24
63
498
100
548
1.15
0.67
1.5
1.5
—
—
—
0
0
100
548
1.15
0.67
1.5
1.5
—
—
—
0
0
51
391
0.82
0.67
7.7
8.3
—
—
—
0
0
26
123
1.33
0.65
1.1
1.1
—
—
—
0
0
70
520
0.85
0.65
1.7
1.3
12.5
12.3
iu/l
0.03
57
411
421
2833
0.94
0.65
1.1
1.1
106.6
97.4
iu/ml
0.20
132
874
109
604
1.14
0.64
3.4
4.2
200.9
162.0
nmol/l
0.29
109
598
14
59
1.50
0.64
1.2
1.2
—
—
—
0
0
54
409
0.83
0.63
1.4
1.3
1.3
1.4
g/l
—
6
33
6
68
0.56
0.63
1.3
1.2
—
—
—
0
0
12
49
1.55
0.62
1.1
1.1
3.3
2.7
u/l
—
5
7
113
630
1.13
0.61
1.3
1.3
82.5
73.7
titre
—
8
52
93
671
0.87
0.61
1.1
1.1
—
—
—
0
0
0
15
0.00
0.60
0.0
1.6
—
22.4
—
0
5
70
514
0.86
0.59
1.5
1.4
—
—
—
0
0
121
855
0.89
0.58
1.2
1.3
1.2
1.4
promille
0.53
106
654
5
56
0.56
0.58
1.0
1.1
20.3
21.7
%
—
5
49
5
56
0.56
0.58
1.0
1.0
8.4
8.8
%
—
5
49
5
56
0.56
0.58
1.0
1.1
36.9
36.9
%
—
5
49
29
231
0.79
0.56
1.4
1.3
0.8
0.9
mmol/l
0.08
19
153
83
599
0.87
0.56
2.3
2.7
31.5
34.9
%
0.57
30
199
15
131
0.72
0.55
10.8
8.6
0.3
0.3
umol/l
0.32
15
120
743
4495
1.05
0.55
1.3
1.3
59.0
57.2
au/ml
0.06
33
186
54
402
0.85
0.55
2.3
2.3
52.8
57.5
umol/l
0.72
41
329
48
361
0.84
0.55
1.1
1.2
—
—
—
0
0
84
604
0.88
0.54
1.4
1.4
67.4
63.0
%
0.63
66
488
151
1049
0.91
0.54
1.1
1.2
28.6
40.9
u/ml
—
5
89
598
3602
1.05
0.54
2.2
2.4
36.6
37.2
g/l
1.51
490
3113
6
63
0.60
0.53
1.0
1.1
—
—
—
0
0
19
89
1.35
0.53
1.1
1.0
—
—
—
0
0
9
87
0.65
0.53
1.0
1.0
—
—
—
0
0
11
46
1.51
0.53
1.0
1.0
5.5
5.7
mmol/l
0.08
11
32
239
1400
1.08
0.52
1.7
1.5
64.2
63.6
%
0.08
148
930
97
689
0.89
0.52
1.1
1.2
11.0
12.3
mmol/l
0.86
26
263
608
3667
1.05
0.52
1.8
1.8
—
—
—
0
0
13
115
0.71
0.52
1.6
1.3
0.6
1.0
ml/s/173m2
—
8
73
109
615
1.12
0.52
2.6
3.8
—
—
—
0
0
20
95
1.33
0.52
1.1
1.1
—
—
—
0
0
220
1286
1.08
0.51
3.2
3.5
—
—
—
0
0
25
123
1.28
0.51
1.6
1.7
41.6
45.9
umol/l
0.46
25
123
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
35
269
0.82
0.51
1.6
1.9
201.6
191.5
%
0.27
30
250
722
4377
1.04
0.50
2.2
2.5
3.2
3.0
g/l
2.36
537
3433
143
991
0.91
0.50
1.1
1.1
—
—
—
0
0
155
1067
0.92
0.48
1.2
1.2
4.2
3.7
u/ml
0.13
57
392
56
304
1.16
0.47
2.7
3.0
—
—
—
0
0
350
2088
1.06
0.47
2.4
1.2
43.2
38.4
u/l
0.26
297
1808
16
134
0.75
0.47
1.1
1.2
393755.2
9.7
nmol/l
0.48
16
115
27
211
0.81
0.47
1.3
1.5
11.5
9.8
ug/l
0.71
27
211
11
98
0.71
0.47
1.1
1.1
—
—
—
0
0
34
259
0.83
0.46
1.1
1.2
—
—
—
0
0
56
408
0.87
0.46
5.1
5.6
73.2
70.8
%
0.31
46
335
47
347
0.85
0.46
1.7
2.0
—
—
—
0
0
1951
12049
1.02
0.46
6.3
7.6
11.8
11.3
mmol/l
1.60
1830
11370
14
64
1.38
0.46
1.7
1.6
0.6
0.7
umol/l
—
6
53
45
333
0.85
0.45
1.1
1.1
—
—
—
0
0
16
133
0.76
0.45
1.1
1.2
57.3
102.7
ug/l
—
9
84
36
189
1.20
0.45
1.5
1.2
50.3
71.5
mu/l
0.49
27
134
9
81
0.70
0.44
1.2
1.3
4780.6
1360.4
u/l
—
9
67
116
805
0.91
0.44
1.1
1.1
—
—
—
0
0
207
1400
0.93
0.43
1.1
1.2
3.7
5.7
u/ml
—
10
113
138
799
1.09
0.43
1.6
1.6
32.4
29.0
u/ml
0.28
29
182
66
472
0.88
0.43
1.1
1.1
—
—
—
0
0
0
10
0.00
0.42
0.0
1.2
—
—
—
0
0
45
243
1.17
0.42
1.1
1.1
—
—
—
0
0
22
110
1.26
0.42
1.1
1.2
—
—
—
0
0
23
180
0.81
0.42
1.7
1.2
70.6
76.9
%
0.21
11
115
236
1586
0.94
0.41
1.1
1.2
2.7
7.1
u/ml
0.85
14
163
35
262
0.84
0.41
1.0
1.3
15.1
19.5
umol/l
0.31
28
188
18
145
0.78
0.41
1.3
1.3
96.4
80.5
%
—
7
71
11
49
1.42
0.41
1.2
1.1
4.0
1.0
u/field
—
6
29
4600
29389
0.98
0.41
2.9
3.2
6528.7
5304.6
umol/l
0.75
3802
25315
279
1663
1.06
0.41
1.4
1.6
—
—
—
0
0
226
1520
0.94
0.41
1.1
1.2
—
10.8
—
0
17
13
60
1.37
0.41
1.1
1.2
2.0
2.0
umol/24h
0.03
13
60
156
912
1.08
0.40
1.3
1.3
277.3
280.6
mosm/kgh2o
0.76
119
718
29
220
0.83
0.40
1.4
1.3
34.5
224.8
u/l
0.64
20
163
239
1602
0.94
0.39
1.1
1.2
3.8
6.9
u/ml
1.33
21
240
114
658
1.09
0.39
1.3
1.3
114.3
438.5
titre
—
7
75
114
658
1.09
0.39
1.6
1.8
76.3
77.3
umol/l
—
6
36
500
3287
0.96
0.39
3.1
3.5
4.4
4.3
pmol/l
0.27
442
2933
5
22
1.43
0.39
1.8
1.1
1121.5
480.1
nmol/l
—
5
22
9
41
1.39
0.39
1.1
1.1
190.7
313.1
u/l
—
9
35
45
327
0.87
0.38
1.1
1.1
1.0
1.1
u/l
0.38
23
166
734
4785
0.97
0.38
2.6
2.8
—
—
—
0
0
375
2477
0.95
0.37
2.1
2.4
214.0
207.5
%
0.69
350
2354
16
78
1.30
0.37
1.1
1.1
11.8
10.9
u/l
0.06
16
78
27
141
1.21
0.37
1.1
1.0
—
—
—
0
0
104
716
0.92
0.36
2.2
2.4
514.5
549.6
e6/l
0.26
51
294
49
352
0.88
0.36
1.1
1.1
1.2
1.1
ratio
0.65
15
108
141
958
0.93
0.36
1.5
1.8
—
—
—
0
0
95
656
0.91
0.35
1.8
2.0
18.6
16.5
%
0.50
36
239
61
431
0.89
0.35
1.2
1.2
—
—
—
0
0
16
79
1.28
0.34
6.5
3.7
—
—
—
0
0
41
297
0.87
0.34
1.1
1.4
0.1
0.1
nmol/l
0.38
29
246
63
356
1.12
0.34
1.3
1.3
—
—
—
0
0
32
236
0.86
0.34
1.0
1.2
—
—
—
0
0
34
249
0.86
0.33
1.2
1.1
98.4
98.0
%
0.02
24
199
1147
7077
1.02
0.33
2.4
2.6
368.0
372.7
nmol/l
0.28
1068
6533
12
57
1.33
0.33
1.0
1.2
—
—
—
0
0
131
888
0.93
0.33
1.2
1.1
7.3
7.9
mmol/l
1.14
87
620
91
626
0.92
0.32
1.8
2.0
—
—
—
0
0
48
342
0.89
0.32
2.0
2.2
46.1
44.9
u/l
0.02
43
313
179
1064
1.06
0.32
1.8
1.3
231.6
247.7
pmol/l
0.40
137
770
34
248
0.87
0.32
1.1
1.1
—
—
—
0
0
82
474
1.09
0.30
1.7
2.1
—
—
—
0
0
8
69
0.73
0.30
1.1
1.1
—
—
—
0
0
64
445
0.91
0.29
1.1
1.5
—
—
—
0
0
68
471
0.91
0.29
1.1
1.2
—
—
—
0
0
26
192
0.85
0.29
1.4
1.3
281.6
183.9
titre
—
5
22
309
1871
1.04
0.29
5.9
6.0
12.1
11.7
mg/l
0.76
292
1708
100
585
1.08
0.29
2.3
2.5
527.4
521.5
e6/l
0.02
85
503
20
151
0.84
0.28
1.3
1.3
53.0
46.0
%
—
9
48
9
74
0.77
0.28
1.6
2.0
17.6
17.2
umol/l
—
9
74
43
241
1.13
0.28
1.0
1.1
—
—
—
0
0
8
40
1.26
0.28
2.0
1.5
0.7
2.4
%
—
8
40
238
1573
0.95
0.28
1.3
1.3
—
—
—
0
0
22
164
0.85
0.28
1.3
1.1
17.5
16.7
u/l
0.10
15
105
1299
8051
1.02
0.27
8.2
9.7
0.6
0.7
%
8.74
1286
7991
90
613
0.93
0.27
1.0
1.1
2.3
4.7
u/ml
1.67
25
196
15
116
0.82
0.27
1.3
2.7
—
—
—
0
0
233
1539
0.96
0.27
1.1
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
19
143
0.84
0.26
1.1
1.3
84.9
73.2
%
—
8
68
522
3200
1.03
0.26
2.3
2.5
0.0
0.0
g/l
0.00
471
2944
421
2746
0.97
0.26
1.8
2.2
87.9
84.1
%
3.26
397
2616
41
290
0.89
0.26
1.4
1.3
37.5
32.0
%
0.35
28
191
25
183
0.86
0.26
1.0
1.2
—
—
—
0
0
55
382
0.91
0.26
1.1
1.2
78.4
50.2
%
—
5
39
86
585
0.93
0.26
1.4
1.4
14.5
15.5
umol/l
0.60
80
543
570
3502
1.03
0.25
2.3
2.4
0.1
0.0
g/l
0.65
512
3186
44
309
0.90
0.25
1.2
1.4
25.7
48.4
g/l
0.61
38
238
9
47
1.21
0.25
9.6
9.8
—
—
—
0
0
25
182
0.87
0.24
1.1
1.1
81.4
80.1
%
0.06
13
116
395
2573
0.97
0.24
1.2
1.2
—
—
—
0
0
5
23
1.37
0.24
1.0
1.2
—
—
—
0
0
74
433
1.08
0.23
1.3
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
70
477
0.93
0.23
1.1
1.1
—
—
—
0
0
207
1252
1.04
0.23
1.4
1.3
14.4
14.5
u/l
0.02
190
1167
10
79
0.80
0.22
1.1
1.0
—
—
—
0
0
294
1920
0.97
0.22
1.5
1.6
—
—
—
0
0
0
8
0.00
0.22
0.0
1.0
—
0.8
—
0
8
0
8
0.00
0.22
0.0
1.5
—
—
—
0
0
21
114
1.16
0.22
1.1
1.5
0.4
0.4
ug/l
0.35
14
72
60
410
0.92
0.21
1.1
1.1
—
—
—
0
0
291
1776
1.03
0.21
1.1
1.1
—
—
—
0
0
0
9
0.00
0.21
0.0
1.0
—
—
—
0
0
529
3261
1.02
0.20
2.3
2.5
0.0
0.0
g/l
0.87
473
2955
2055
12828
1.01
0.20
8.1
8.6
—
—
—
0
0
253
1542
1.04
0.20
1.4
1.3
491.4
542.3
u/l
0.14
238
1461
77
519
0.94
0.20
1.0
1.1
—
—
—
0
0
94
560
1.06
0.19
2.3
2.6
0.3
0.3
e9/l
0.00
85
504
408
2510
1.03
0.19
2.8
3.4
216.4
1122.8
u/ml
2.63
362
2297
63
370
1.08
0.19
1.3
1.2
43.2
40.3
g/l
0.84
35
199
27
191
0.89
0.19
1.1
1.2
—
—
—
0
0
15
111
0.85
0.18
1.1
1.1
—
—
—
0
0
171
1037
1.04
0.18
3.3
3.1
42.4
63.3
mg/l
0.84
127
797
25
140
1.13
0.18
1.5
1.6
27.3
50.3
pmol/l
1.54
20
112
74
439
1.06
0.18
1.3
1.2
—
—
—
0
0
5
43
0.73
0.17
1.0
1.0
—
—
—
0
0
1167
7465
0.99
0.17
3.6
3.6
126.6
129.2
g/l
3.53
1133
7283
32
183
1.10
0.17
1.1
1.1
—
—
—
0
0
963
6169
0.98
0.17
3.9
3.8
24.9
25.0
mmol/l
0.12
932
5982
808
5019
1.02
0.17
2.4
2.4
35.9
27.0
au/ml
0.39
21
144
294
1908
0.97
0.17
1.2
1.2
—
—
—
0
0
190
1158
1.04
0.17
1.4
1.5
—
—
—
0
0
8
44
1.15
0.16
1.0
1.2
—
—
—
0
0
1295
8077
1.01
0.16
8.0
9.6
1.2
1.4
%
4.94
1283
8012
866
5549
0.98
0.16
2.8
2.9
0.7
0.7
%
0.50
824
5343
87
521
1.05
0.16
1.3
1.4
3.8
3.8
mmol/l
0.06
77
476
6
48
0.79
0.16
1.0
1.0
—
—
—
0
0
6
49
0.77
0.16
1.2
1.0
—
—
—
0
0
31
178
1.10
0.16
1.2
1.2
—
—
—
0
0
31
178
1.10
0.16
1.2
1.2
—
—
—
0
0
100
602
1.05
0.16
1.2
1.5
—
—
—
0
0
9
49
1.16
0.15
1.1
1.6
—
—
—
0
0
12
89
0.85
0.15
1.0
1.1
—
—
—
0
0
37
215
1.09
0.15
1.2
1.1
—
—
—
0
0
84
504
1.05
0.15
1.3
1.3
69.4
268.0
ug/l
1.44
44
257
392
2422
1.02
0.15
3.0
2.9
0.8
0.8
nmol/l
0.27
279
1842
490
3035
1.02
0.15
1.6
1.6
—
—
—
0
0
100
603
1.05
0.15
1.2
1.5
—
—
—
0
0
57
338
1.06
0.15
1.4
1.6
2.9
61.9
u/l
0.74
16
55
10
75
0.84
0.14
1.1
1.0
—
—
—
0
0
35
239
0.92
0.14
1.1
1.1
—
—
—
0
0
70
465
0.95
0.13
1.1
1.1
49.8
55.7
mg/l
0.36
54
403
63
377
1.06
0.13
1.1
1.1
—
—
—
0
0
26
150
1.09
0.12
1.2
1.2
—
—
—
0
0
34
199
1.08
0.12
1.4
1.3
—
—
—
0
0
79
521
0.96
0.12
1.4
1.4
2.9
2.5
%
0.17
65
430
25
172
0.92
0.12
1.4
1.6
—
—
—
0
0
37
218
1.07
0.12
1.2
1.3
—
—
—
0
0
34
230
0.93
0.11
1.4
1.6
—
—
—
0
0
28
191
0.93
0.11
1.1
1.1
—
—
—
0
0
196
1207
1.03
0.11
1.4
1.5
5.1
4.1
iu/l
0.33
47
330
1482
9281
1.01
0.11
3.2
3.4
4.5
4.6
kpa
0.81
1433
8926
171
1052
1.03
0.10
1.5
1.7
—
—
—
0
0
171
1052
1.03
0.10
1.5
1.7
—
—
—
0
0
171
1052
1.03
0.10
1.5
1.7
—
—
—
0
0
29
197
0.93
0.10
1.6
1.4
70.2
70.2
%
0.00
24
160
23
133
1.09
0.10
1.2
1.2
0.7
0.7
umol/24h
0.03
13
60
35
235
0.94
0.10
1.1
1.1
—
—
—
0
0
147
904
1.03
0.10
1.3
1.3
—
—
—
0
0
62
376
1.04
0.08
1.5
1.7
2175.2
17842.7
u/ml
—
6
63
1274
8098
0.99
0.08
8.3
9.8
94.2
93.5
%
3.04
1269
8069
5
40
0.79
0.08
1.0
1.0
—
—
—
0
0
890
5665
0.99
0.08
4.4
4.4
46.7
47.5
%
0.45
879
5595
63
413
0.96
0.08
3.4
4.1
13.3
13.4
%
0.48
63
407
342
2129
1.01
0.08
1.3
1.5
—
—
—
0
0
40
240
1.05
0.08
1.4
1.5
7.9
9.1
%
0.19
21
111
26
175
0.94
0.08
1.2
1.3
—
—
—
0
0
6
46
0.82
0.08
1.0
1.1
250.2
233.7
nmol/l
—
6
46
6
46
0.82
0.08
1.0
1.5
—
—
—
0
0
1285
8062
1.01
0.07
6.5
7.8
24.4
24.4
mmol/l
0.16
1184
7556
306
1905
1.01
0.07
1.3
1.4
—
—
—
0
0
894
5686
0.99
0.07
2.8
2.9
1.2
1.2
%
0.60
885
5663
90
584
0.97
0.07
2.3
2.4
—
—
—
0
0
10
71
0.89
0.07
1.2
1.1
8.5
11.6
mmol/l
—
5
36
35
232
0.95
0.07
1.1
1.1
—
—
—
0
0
19
129
0.93
0.07
3.5
3.4
1.3
1.2
mg/l
0.14
13
111
1082
6872
0.99
0.06
1.2
1.2
—
—
—
0
0
309
1975
0.99
0.06
1.5
1.5
1838.3
2859.3
e6/l
0.89
225
1454
67
436
0.97
0.06
1.1
1.1
347.0
376.1
mg/l
0.39
52
393
22
148
0.94
0.06
1.6
1.5
—
—
—
0
0
44
289
0.96
0.06
1.1
1.0
—
—
—
0
0
26
155
1.06
0.06
1.0
1.1
—
—
—
0
0
35
231
0.96
0.06
1.1
1.1
—
—
—
0
0
33
218
0.96
0.06
1.3
1.4
21.1
25.4
%
0.35
23
166
10
70
0.90
0.05
1.0
1.2
—
—
—
0
0
10
70
0.90
0.05
4.3
3.7
—
—
—
0
0
177
1133
0.99
0.05
1.6
1.8
—
—
—
0
0
58
356
1.03
0.05
1.4
1.5
56.3
88.3
umol/l
1.13
23
181
36
236
0.96
0.04
1.1
1.1
—
—
—
0
0
27
163
1.05
0.04
1.0
1.1
—
—
—
0
0
77
476
1.02
0.04
1.0
1.1
4.5
6.8
nmol/l
0.45
17
108
339
2157
0.99
0.04
1.2
1.2
—
—
—
0
0
18
107
1.06
0.04
1.1
1.1
—
—
—
0
0
17
101
1.06
0.04
1.0
1.1
—
—
—
0
0
276
1728
1.01
0.03
1.3
1.5
—
—
—
0
0
35
214
1.03
0.03
1.3
1.1
313.8
213.9
pmol/l
0.77
23
156
81
503
1.02
0.03
1.1
4.7
58.8
822.6
mg/l
0.82
55
368
355
2228
1.01
0.03
1.5
1.5
31.2
32.3
g/l
0.96
302
2012
187
1171
1.01
0.02
1.4
1.4
12.7
13.3
u/l
0.70
179
1126
274
1719
1.01
0.02
1.3
1.4
—
—
—
0
0
13
77
1.07
0.02
1.2
1.1
—
—
—
0
0
44
272
1.02
0.02
1.1
1.0
23.0
10.0
iu/ml
—
7
68
40
258
0.98
0.01
1.1
1.1
1451.8
1614.4
miu/ml
0.34
40
258
342
2167
1.00
0.01
1.2
1.2
—
—
—
0
0
24
147
1.03
0.01
1.4
1.3
—
—
—
0
0
237
1490
1.00
0.01
1.5
1.4
6.1
6.3
mmol/l
0.49
208
1381
10
59
1.07
0.01
1.1
1.3
1.3
1.3
%
—
10
59
45
280
1.01
0.00
1.2
1.3
168.2
141.7
nmol/l
0.25
32
216
188
1191
1.00
0.00
1.5
1.8
—
—
—
0
0
413
2611
1.00
0.00
1.0
1.1
—
—
—
0
0
16
103
0.98
0.00
1.3
1.6
—
—
—
0
0
27
173
0.99
0.00
1.2
1.2
4246.7
152.7
ng/l
0.52
14
125
17
108
0.99
0.00
1.3
1.5
—
—
—
0
0
286
1804
1.00
0.00
1.5
1.5
77243.1
64570.6
e6/l
0.18
182
1116
173
1091
1.00
0.00
1.6
1.4
24.7
24.1
%
0.09
102
727
28
179
0.99
0.00
1.0
1.1
—
—
—
0
0
38
238
1.01
0.00
1.2
1.1
—
—
—
0
0
65
407
1.01
0.00
1.1
1.1
—
—
—
0
0
70
444
1.00
0.00
1.5
1.4
4.1
1.3
u/ml
0.96
40
270
23
148
0.98
0.00
1.2
1.2
—
—
—
0
0
17
110
0.98
0.00
4.4
4.0
—
—
—
0
0
64
402
1.01
0.00
1.4
1.4
15.3
23.2
%
1.80
50
336
31
194
1.01
0.00
1.1
1.2
163.4
0.9
mg/l
0.48
24
147
11
69
1.01
0.00
1.1
1.3
364.7
353.3
umol/24h
0.04
11
69
57
361
1.00
0.00
1.1
1.1
449.7
796.9
ng/l
0.48
19
94
7
44
1.00
0.00
1.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
6
43
0.88
0.00
1.0
1.0
—
—
—
0
0
6
39
0.97
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_PROSTATE – Malignant neoplasm of prostate
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).